Pro-Dex, Inc. (PDEX)
NASDAQ: PDEX · Real-Time Price · USD
35.70
-0.69 (-1.90%)
At close: Sep 10, 2025, 4:00 PM
35.46
-0.24 (-0.67%)
After-hours: Sep 10, 2025, 4:34 PM EDT
Pro-Dex Revenue
In the fiscal year ending June 30, 2025, Pro-Dex had annual revenue of $66.59M with 23.68% growth. Pro-Dex had revenue of $17.49M in the quarter ending June 30, 2025, with 16.43% growth.
Revenue (ttm)
$66.59M
Revenue Growth
+23.68%
P/S Ratio
1.80
Revenue / Employee
$367,917
Employees
181
Market Cap
115.80M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 66.59M | 12.75M | 23.68% |
Jun 30, 2024 | 53.84M | 7.76M | 16.83% |
Jun 30, 2023 | 46.09M | 4.05M | 9.62% |
Jun 30, 2022 | 42.04M | 4.01M | 10.55% |
Jun 30, 2021 | 38.03M | 3.20M | 9.17% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
PDEX News
- 6 days ago - Pro-Dex, Inc. Announces Fiscal 2025 Fourth Quarter and Full-Year Results - Accesswire
- 4 months ago - Pro-Dex: Crash After Strong Earnings Leads To A Buying Opportunity - Seeking Alpha
- 4 months ago - Pro-Dex, Inc. Announces Fiscal 2025 Third Quarter and Nine-Month Results - Accesswire
- 7 months ago - Q4 2024 Portfolio Update: Growth Has Come Patiently - Seeking Alpha
- 7 months ago - Pro-Dex, Inc. Announces Fiscal 2025 Second Quarter and Six-Month Results - Accesswire
- 11 months ago - PRO-DEX, INC. Announces Fiscal 2025 First Quarter Results - Accesswire
- 1 year ago - Pro-Dex Inc (PDEX) Stock Price Up 3.99% on Oct 2 - GuruFocus
- 1 year ago - Pro-Dex, Inc. Announces Fiscal 2024 Fourth Quarter and Full-Year Results - Accesswire